Myocardial necrosis in a newborn after long-term maternal subcutaneous terbutaline infusion for suppression of preterm labor.
We report a case of myocardial necrosis in a newborn after treatment of the mother with long-term subcutaneous terbutaline. No such serious side effects in the fetus have previously been reported. We speculate that this myocardial damage was due to beta-sympathomimetic therapy.
Fletcher
S E
SE
Division of Pediatric Cardiology, Medical University of South Carolina, Charleston.
Fyfe
D A
DA
Case
C L
CL
Wiles
H B
HB
Upshur
J K
JK
Newman
R B
RB
D002216:Captopril / Q000627:therapeutic use; D009202:Cardiomyopathies / Q000209:etiology*; D004077:Digoxin / Q000627:therapeutic use; D004452:Echocardiography; D004562:Electrocardiography; D005260:Female; D005665:Furosemide / Q000627:therapeutic use; D006801:Humans; D007231:Infant, Newborn; D007279:Injections, Subcutaneous; D008297:Male; D009336:Necrosis / Q000209:etiology; D007752:Obstetric Labor, Premature / Q000188:drug therapy*; D011247:Pregnancy; D013726:Terbutaline / Q000009:adverse effects*
D004077:Digoxin; D005665:Furosemide; D002216:Captopril; D013726:Terbutaline